No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs10011145 |
chr4:147553803-147553804 |
Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs74938169 |
chr4:147553844-147553845 |
Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs537692814 |
chr4:147553869-147553870 |
Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs557159745 |
chr4:147553935-147553936 |
Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs577295295 |
chr4:147553967-147553968 |
Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs117928174 |
chr4:147553974-147553975 |
Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs538309988 |
chr4:147553984-147553985 |
Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs557134298 |
chr4:147553990-147553991 |
Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs76834995 |
chr4:147554009-147554010 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs189155394 |
chr4:147554027-147554028 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs550817006 |
chr4:147554061-147554062 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs574281530 |
chr4:147554127-147554128 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs543634261 |
chr4:147554210-147554211 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs566397812 |
chr4:147554216-147554217 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs569100714 |
chr4:147554261-147554262 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs71593783 |
chr4:147554269-147554270 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs149281723 |
chr4:147554270-147554271 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs375858983 |
chr4:147554271-147554272 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs532251981 |
chr4:147554276-147554277 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs185574845 |
chr4:147554280-147554281 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs34844786 |
chr4:147554283-147554284 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs114258073 |
chr4:147554284-147554285 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs559395300 |
chr4:147554299-147554300 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs116441614 |
chr4:147554339-147554340 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs17021726 |
chr4:147554354-147554355 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs142031434 |
chr4:147554407-147554408 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs188765974 |
chr4:147554417-147554418 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs551176001 |
chr4:147554462-147554463 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs370773360 |
chr4:147554503-147554504 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs566602247 |
chr4:147554560-147554561 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs77525277 |
chr4:147554561-147554562 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs181367546 |
chr4:147554570-147554571 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs186697826 |
chr4:147554575-147554576 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs72956269 |
chr4:147554593-147554594 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs540206632 |
chr4:147554606-147554607 |
Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs535496043 |
chr4:147554636-147554637 |
Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs10024327 |
chr4:147554684-147554685 |
Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
38 |
rs372301597 |
chr4:147554714-147554715 |
Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs574416745 |
chr4:147554715-147554716 |
Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs543220994 |
chr4:147554738-147554739 |
Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs182103735 |
chr4:147554748-147554749 |
Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs576819182 |
chr4:147554765-147554766 |
Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs187413906 |
chr4:147554839-147554840 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs559532073 |
chr4:147554841-147554842 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs150666739 |
chr4:147554905-147554906 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs367740540 |
chr4:147554998-147554999 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs116070384 |
chr4:147555014-147555015 |
Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs531250525 |
chr4:147555020-147555021 |
Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs112527580 |
chr4:147555023-147555024 |
Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs190615351 |
chr4:147555038-147555039 |
Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|